[Dynamics of cytotoxicity of blood mononuclear cells in patients with bladder cancer during endolymphatic immunotherapy with lymphokine- activated killer cells and recombinant interleukin-2].
Malakhova
N V
NV
Figurin
K M
KM
Fedorova
N S
NS
Kiselevskiĭ
M V
MV
Bykovskaia
S N
SN
D019264:Adoptive Transfer; D003602:Cytotoxicity, Immunologic; D006801:Humans; D007376:Interleukin-2 / Q000627:therapeutic use*; D015979:Killer Cells, Lymphokine-Activated; D009000:Monocytes / Q000276:immunology*; D011994:Recombinant Proteins / Q000627:therapeutic use; D001749:Urinary Bladder Neoplasms / Q000097:blood / Q000276:immunology / Q000628:therapy*
D007376:Interleukin-2; D011994:Recombinant Proteins